Guanidinoacetic Acid Market Strategic Outlook

Guanidinoacetic acid (GAA) or Glycocyamine is the biochemical precursor of creatine, which is phosphorylated. It plays an important role as a high-energy carrier in the muscle. Glycocyamine is actually a metabolite of glycine in which the amino group has been converted into a guanidine.Guanidinoacetic acid can be used to increase muscle strength and to reduce muscle fatigue. And add guanidinoacetic acid into fodder can make lean pig's body improve significantly. GAA might be considered as an innovative way to improve exercise performance.It has recently been suggested as a possible alternative to creatine to tackle brain creatine levels in experimental medicine. Due to upgraded bioavailability and convenient utilization of the compound, taking GAA orally might be benefitial for AGAT patients. But it has several drawbacks like brain methylation issues, neurotoxicity, and hyperhomocysteinemia.  

From studies it has been observed that a combination of betaine and glycocyamine improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine provides methyl group to glycocyamine, via methionine, for the formation of creatine. Because of this, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. It is also useful for the patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure for improving cardiac function. It is also helpful in gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido. People suffering from hypertension experienced transient reduced blood pressure.It also increase of glucose tolerance in both diabetic and without diabetes subjects.  

Geogrphically, Guanidinoacetic Acid Market analysis covers regions- North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).  

Guanidinoacetic Acid Market : By Product Type

• Feed Grade
• Pharmaceutical Grade

Global Guanidinoacetic Acid Market: Companies Covered

• Evonik (Germany)
• GENDONE (China)
• HebeiDaxiao (China)
• TianchengChempharm (China)
• Lubon Industry (China)
• Hubei Yuanhua (China)
• Jiangsu Yuanyang (China)
• Shijiazhuang Zexing (China)

Geographical analysis of Guanidinoacetic Acid Market includes :

• North America
  • U.S.A.
  • Canada
• Europe
  • France
  • Germany
  • Spain
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South East Asia
• Latin America
  • Brazil
• Middle East and Africa

Guanidinoacetic Acid Market Report delivers a comprehensive analysis of the following parameters :

• Market Forecast for 2017-24
• Market growth drivers
• Challenges and Opportunities
• Emerging and Current Market trends
• Market player Capacity, Production, Revenue (Value)
• Supply (Production), Consumption, Export, Import analysis
• End-user/application Analysis